Rhonda Lynette Hellums serves as Executive at ARATANA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Rhonda Lynette Hellums has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 18, 2019 involved selling 51,424 shares valued at $0.
Rhonda Lynette Hellums currently holds 51,424 shares of ARATANA THERAPEUTICS, INC. (PETX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rhonda Lynette Hellums has been a net neutral trader of PETX stock. They have purchased $0 and sold $0 worth of shares.
Rhonda Lynette Hellums's most recent insider trade was on Jul 18, 2019, when they sold 51,424 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |